Nurs fpx 4025 assessment 3

Student Name
Capella University
NURS-FPX4025 Research and Evidence-Based Decision Making
Prof. Name
Date
Chronic Obstructive Pulmonary Disease (COPD) and Smoking Cessation Interventions
Understanding COPD and Its Challenges: Nurs fpx 4025 assessment 3
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing difficult. It is characterized by persistent respiratory symptoms such as coughing, shortness of breath, and frequent lung infections. Without proper management, COPD can worsen over time, leading to frequent hospitalizations, heart complications, and even respiratory failure. One of the most effective ways to slow disease progression is smoking cessation. However, quitting smoking remains challenging due to nicotine addiction, stress, and lack of support (American Lung Association [ALA], 2024).
Certain populations experience greater difficulty managing COPD. Older adults, low-income individuals, and those with limited healthcare access struggle more with obtaining necessary treatments (Alupo et al., 2024). Many patients cannot afford inhalers, oxygen therapy, or regular doctor visits, leading to deteriorating health and increased hospital admissions. Additionally, geographical barriers prevent some patients from accessing timely medical care, further exacerbating their condition. Providing structured smoking cessation support and ensuring access to healthcare can help reduce these risks (Wang et al., 2024). Nurses play a vital role in educating and assisting COPD patients, ensuring they receive adequate support for smoking cessation and disease management.
Research Question and PICO(T) Framework
A well-defined research question is essential in determining the most effective interventions for smoking cessation in COPD patients (Gosak et al., 2024). Using the PICO(T) framework, the research question for this study is: In adult patients diagnosed with COPD (P), how does a structured smoking cessation program incorporating behavioral counseling and pharmacotherapy (I) compared to standard smoking cessation counseling (C) affect smoking cessation rates and pulmonary function (O) within six months (T)?
Breakdown of PICO(T) Criteria: Nurs fpx 4025 assessment 3
- Population (P): Adult patients diagnosed with COPD. This group is selected because smoking is a major contributor to COPD progression, making cessation a primary treatment goal.
- Intervention (I): A structured smoking cessation program involving behavioral counseling and pharmacotherapy, such as nicotine replacement therapy (NRT), varenicline, or bupropion. Studies suggest that multi-component cessation programs yield better results than single interventions (Fu et al., 2022).
- Comparison (C): Standard smoking cessation counseling, typically consisting of brief physician advice or informational materials.
- Outcome (O): Improved smoking cessation rates and better pulmonary function.
- Time (T): Six months, as research indicates that maintaining abstinence for this period significantly predicts long-term cessation success (Hu et al., 2021).
Addressing Barriers to Smoking Cessation in COPD Patients: Nurs fpx 4025 assessment 3
By addressing barriers to quitting, such as socioeconomic factors and limited healthcare access, this study aims to determine which method produces better long-term smoking cessation outcomes. The findings will help nurses implement effective strategies to support COPD patients, reducing disease complications and improving their quality of life.
Literature Search and Relevant Evidence
A comprehensive literature search was conducted using databases such as PubMed, CINAHL, Cochrane Library, and Google Scholar. Keywords included “COPD,” “smoking cessation,” “nicotine replacement therapy,” “behavioral counseling,” and “pulmonary rehabilitation.” Boolean operators (AND, OR) were used to refine searches, ensuring results focused specifically on COPD-related smoking cessation. Studies were evaluated using the CRAAP criteria (Currency, Relevance, Authority, Accuracy, and Purpose) to ensure credibility. Preference was given to peer-reviewed journal articles, systematic reviews, and recent publications within the last five years.
Summary of Key Studies: Nurs fpx 4025 assessment 3
| Study | Findings | Relevance |
|---|---|---|
| Wang et al. (2024) | Meta-analysis of 11 studies found improved lung function (FEV1% +6.72, FEV1/FVC +6.82), better exercise capacity (6-MWT +64.46m), and reduced mortality (RR = 0.75) in COPD patients who quit smoking. | Strong evidence supporting smoking cessation benefits, highlighting structured programs’ role in disease management. |
| Han et al. (2023) | Randomized controlled trial (RCT) demonstrated that combining NRT with cognitive-behavioral therapy (CBT) increased quit rates compared to standard counseling alone. | RCT provides high credibility, showing structured programs’ effectiveness over brief counseling. |
| Fu et al. (2022) | Implementation of the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model improved adherence to structured smoking cessation programs, leading to better pulmonary outcomes. | Relevant to nursing practice, emphasizing the importance of integrating structured interventions. |
The evidence suggests that structured smoking cessation programs incorporating behavioral counseling and pharmacotherapy lead to better long-term cessation rates and improved lung health in COPD patients. This supports the integration of structured interventions into nursing care.
Conclusion
Quitting smoking is crucial for COPD patients to slow disease progression and improve overall health. Structured smoking cessation programs that include counseling and pharmacotherapy prove to be more effective than standard counseling alone. Patients who quit smoking experience better lung function, enhanced exercise capacity, and lower hospitalization rates. Healthcare providers, particularly nurses, play a key role in implementing these programs to improve patient outcomes. By integrating structured smoking cessation strategies into routine care, COPD patients can achieve better long-term health and a higher quality of life.
References
Alupo, P., Baluku, J., Bongomin, F., Siddharthan, T., Katagira, W., Ddungu, A., Hurst, J. R., Boven, van, Worodria, W., & Kirenga, B. J. (2024). Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries. Expert Review of Respiratory Medicine. https://doi.org/10.1080/17476348.2024.2398639
American Lung Association (ALA). (2024). Learn about COPD | American Lung Association. Lung.org. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/learn-about-copd
Centers for Disease Control and Prevention (CDC). (2024, June 12). COPD. Chronic Disease Indicators. https://www.cdc.gov/cdi/indicator-definitions/chronic-obstructive-pulmonary-disease.html
Nurs fpx 4025 assessment 3
Fu, Y., Chapman, E. J., Boland, A. C., & Bennett, M. I. (2022). Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review. Palliative Medicine, 36(5), 770–782. https://doi.org/10.1177/02692163221079697
Gosak, L., Štiglic, G., Pruinelli, L., & Vrbnjak, D. (2024). PICOT questions and search strategies formulation: A novel approach using artificial intelligence automation. Journal of Nursing Scholarship. https://doi.org/10.1111/jnu.13036
Han, M. K., Fu, Y., Ji, Q., Duan, X., & Fang, X. (2023). The effectiveness of theory-based smoking cessation interventions in patients with chronic obstructive pulmonary disease: A meta-analysis. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-16441-w
Nurs fpx 4025 assessment 3
Hu, Y., Xie, J., Chang, X., Chen, J., Wang, W., Zhang, L., Zhong, R., Chen, O., Yu, X., & Zou, Y. (2021). Characteristics and predictors of abstinence among smokers of a smoking cessation clinic in Hunan China. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.615817
Wang, Z., Qiu, Y., Ji, X., & Dong, L. (2024). Effects of smoking cessation on individuals with COPD: A systematic review and meta-analysis. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1433269